CHOCMSC StudyEffects of mesenchymal stem cells administration on organ failure during septic shock: Phase II randomized placebo-controlled study - CHOCMSC Study

Centre Hospitalier Régional Universitaire de Nancy0 个研究点目标入组 66 人开始时间: 2018年1月15日最近更新: 2021年5月3日

适应症

试验速览

暂无简介。

•1-Male Patient 18 years of age or older, or Woman over 65 years
•2-Presence of community-acquired septic shock for less than 12 hours and associated with at least 2 organ failure other than cardiovascular. The time of septic shock onset is defined as the time of catecholamines introduction
•3-Septic shock occurring between Monday 8:00 am and Friday 8:00 am (for reasons of availability of the staff of the UTCT)
•4-Prior receipt of written consent (patient / trusted person / family member)
•5-Person affiliated to a Social Security
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 33
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 33

•1-Shock of non-septic origin
•2-Nosocomial septic shock
•3-PaO2 / FiO2 ratio <100
•4-Female under 65 years
•5-brain death
•6-Moribund patient
•7-Initial limatation of care or DNR orders
•8-Patient already enrolled in another interventional tria, ongoing or for less than 30 days

发起方

Centre Hospitalier Régional Universitaire de Nancy